The FDA has approved Octagam 10% liquid preparation for the treatment of adults with chronic immune thrombocytopenic purpura (ITP).
Multicentric Castleman’s disease (MCD) in adults who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.
A significant increase in the risk of heart attack was seen I patients with Sjӧgren's syndrome (SjS), especially in the first year following diagnosis.
New research showed that it is possible to successfully stop immunosuppressant therapy without triggering a flare for the majority of lupus patients in remission.
A new study showed that a single episode of binge drinking can cause bacteria leakage from the gut and increase levels of endotoxins in the ...
Janssen Biotech announced that the FDA has approved Sylvant (siltuximab) for the treatment of patients with multicentric Castleman's disease (MCD).
Review this chart on Hematological Reference Values for quick information when you need it.
With this certified-for-credit activity, review cases including "A collaborative approach to myasthenia gravis."